Exam 2: Enteral Nutrition Flashcards

1
Q

Explain the steps in the decision making process for if, when, and how to provide nutrition support

A

(1) anticipated length of time enteral feeding will be required, (2) degree of risk for aspiration or tube dis- placement, (3) patient’s clinical status, (4) adequacy of digestion and absorption, (5) patient’s anatomy (e.g., after previous surgical resection or in extreme obesity), and (6) whether future surgical intervention is planned.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Identify 4 conditions that my require enteral nutrition

A
  1. impaired nutrient intake
  2. inability to consume adequate nutrition orally
  3. impaired digestion, absorption, metabolism
  4. severe wasting or depressed growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What situations do patients have impaired nutrient intake?

A

neurological disorders, trauma, congenital anomalies, respiratory failure, traumatic brain/spinal cord injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In what situations do patients have the inability to consume adequate nutrition orally?

A

Hyperemesis of pregnancy; hypermetabolic = burns; anorexia in
congestive heart failure, cancer, COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In what situations do patients have impaired digestion, absorption, or metabolism?

A

Severe gastroparesis, inborn errors of metabolism (GI), Crohn’s
disease, short bowel syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

In what situations do patients have severe wasting or depressed growth?

A

Cancer
Cerebral palsy
Cystic fibrosis
FTT
Myasthenia gravis
Sepsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe proposed benefits of enteral nutrition vs. parenteral nutrition

A

Better gastrointestinal barrier function
 More “physiologic”
 Preserved gastrointestinal immunity
 Preserved gut-associated lymphoid
tissue (GALT) activity
 Microbiome support
 Decreased rates of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Distinguish between the tubes used for enteral nutrition

A
  • Nasogastric
  • Nasoenteric
  • Gastrostomy
  • Gastrojejunal
  • Jejunostomy
  • Transgastric Jejunostomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nasoenteric complications

A

Esophageal strictures
Gastroesophageal reflux resulting in aspiration pneumonia Tracheoesophageal fistula
Incorrect position of the tube leading to pulmonary injury
Mucosal damage at the insertion site
Nasal irritation and erosion
Pharyngeal or vocal cord paralysis
Rhinorrhea, sinusitis, otitis media
Ruptured gastroesophageal varices in hepatic disease
Ulcerations or perforations of the upper gastrointestinal tract and airway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nasogastric patients

A

-nose to stomach
- medication or feeding
- than 3 to 4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nasoduodenal or Nasojejunal patients

A
  • Patients who do not tolerate gastric feedings
  • ## short term
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the 3 access sites for EN?

A

Nasal
Oral
Abdominal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

patient feeding tube if less than 4 week/

A
  • naso enteric
  • oral enteric
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

patient feeding tube if greater than 4 week?

A
  • gastrostomy
  • jejunostomy
  • transgastric jejunostomy
  • gastric/jejunostomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 5 feeding schedules for EN?

A
  • Continuous
  • Intermittent and Cyclic
  • Gravity Drip or Bolus
  • Low Dose “trophic feeding”
  • Initiate “Full Strength”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Continuous feeding schedule?

A
  • duration of 224 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Typical patients receive Continuous feeding

A

Critical care, ICU patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is intermittent and Cyclic feeds?

A
  • duration of 8-20 hours
  • depend on medication, procedures, and weaning
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is Gravity Drip or Bolus Feeding?

A
  • used to assimilate normal feeding pattern
  • 500mL/feeding
20
Q

What is low dose “trophic feeding”

A
  • ICU
  • determine how patient tolerates feeding
21
Q

What is initiate full strength?

A
  • introduce all formulas at full strength, meaning that it is not diluted
22
Q

What is isotonic

A
  • 1 to 1.2 formulas
23
Q

What is hypertonic

A
  • more particles per volume
24
Q

what is normal osmo of GI

A
25
Q

What are open system feeding?

A

feeding
bag with cans
Higher risk of
contamination
o More frequent bag
and tubing changes
o No more than 8
hours of hang time

26
Q

What are closed system feeing?

A
  • Closed System: “Ready
    to hang”
    o Decreased risk of
    contamination
    o Room temperature,
    stable up to 36-48
    hrs
27
Q

Hang time

A

Hang time is the length of time an enteral formula hanging at room temperature is considered safe for delivery to the patient. Most facili- ties allow a 4-hour hang time for a product in an open system and 24 to 48 hours for products in a closed system (manufacturer’s directions should always be followed).

28
Q

Describe the nutrient composition of various enteral nutrition formulas

A

Protein (8-25% of total kcals)
* Predominant sources=soy, whey and casein
* BCAA’s
* Small peptide and AA’s
Carbohydrates (40-75% of total kcals)
* Predominant sources=hydrolyzed cornstarch,
maltodextrin
* corn syrup, fructose, glucose oligosaccharides
Fat (15-45% of total kcals)
* Predominant sources=polyunsaturated fats such
as corn, safflower, sunflower, or soybean oil
* Medium chain triglycerides (MCT) Note: do not
require hydrolysis by bile salts or pancreatic
lipase, BUT no EFA. Made from fractionated
coconut oil.
* Omega 3 fats (ARDS, Immunonutrition, metabolic)

29
Q

What s the Fiber content in EN?

A

Soluble or Insoluble?
Soy Polysaccharide
Content ranges from 0-14
gms/liter
Consider recommended intake
of fiber (20-35 gms/day)
Modular: Benefiber,
Fibersource.
* One packet=1 tbsp., 3 gms fiber

30
Q

What are the 3 disease-specific formulas

A

Renal
hepatic
Diabetic

31
Q

Describe Renal Formula

A

Calorically Dense-2 kcals/mL
* Considerations include:
* Level of renal function
* Non RRT vs RRT

32
Q

Describe Hepatic Formula

A

BCAA’s (valine, leucine, isoleucine) vs AAA’s
(phenylalanine, tyrosine, tryptophan) with
Hepatic Encephalopathy
* MCT fat source (0-66%), total fat 12-30%
* 1.5 kcals/ml

33
Q

Describe Diabetic Formula

A

Carbohydrate Source: oligosaccharides,
fructose, cornstarch
* Soluble fiber (guar, pectin) Improved glycemic
control via delay of gastric emptying and
increased transit time
* Kcal distribution: 34-40% CHO, 42-50% FAT
(small % of MCT oil)
* Avoid overfeeding, appropriate insulin
management

34
Q

What is Respiratory Disease “oxepa”

A

Acute Respiratory Distress
Syndrome (ARDS)
óFISH OILS/Borage Oil:
-Linolenic (GLA) and
Eicosapentanoic acids
(EPA). ? Favorable
conditions for pro-
inflammatory mediators
ó55% of kcals from fat
óVit E, beta-carotene,
selenium, Vitamin C
“Oxepa”

35
Q

What are the specialty formulas and modulars

A

Critical Care/Metabolic
Formulas
Immunonutrition
Formulas
* Indications-?
* Omega 3 PUFA’s, Nucleic Acids,
Selenium, Vitamins A, C, E, Zinc,
Glutamine, Arginine
Glutamine
Arginine

36
Q

Identify markers to monitor in patients receiving nutrition support

A

Body temperature
Intake/output Records
Glucose
Electrolytes: (NA,K,Mg,Ca,PO4,CL)
Renal function
Albumin/TP
Cholesterol/Trigs
H/H-iron status
Nitrogen balance
Prealbumin/CRP
WTS!!!!

37
Q

Recognize potential complications of enteral nutrition

A

Gi complications
Mechanical Complications

38
Q

Describe Gi complications

A

Diarrhea: >3-4 stools per day or >
250-500mL of liquid stool every 8
hours
Nausea and/or vomiting
Constipation: no stool for >3 days
Gastric residuals: > 200-500mL
Food/Drug interactions

39
Q

Describe Mechanical Complications

A
  • Pulmonary Aspiration
  • Tube obstruction
  • Mucosal damage
40
Q

Nutrition Support Decision if the patient is meeting needs orally?

A

no further intervention need, cotinue to onitor

41
Q

Nutrition Support Decision if the patient is not meeting needs orally and has nonfuncional GI tract?

A

Provide Parenteral nutrition

42
Q

Nutrition Support Decision if parenteral nutrition needs are required for greater than 3 weeks

A

Peripheral extended dwell catheters

or

Central tunneled catheters and ports PICC

43
Q

Nutrition Support Decision if parenteral nutrition needs are required for less than 3 weeks

A

Peripheral standard IV catheters

or

Central standard central lines

44
Q

Nutrition Support Decision if the patient is not meeting needs orally but still requires fortified food and oral supplements >75% of needs

A

provide enteral gastric feeding

45
Q
A